343 related articles for article (PubMed ID: 38016685)
21. Progressive brain microstructural damage in patients with multiple sclerosis but not in patients with neuromyelitis optica spectrum disorder: A cross-sectional and follow-up tract-based spatial statistics study.
Chen X; Roberts N; Zheng Q; Peng Y; Han Y; Luo Q; Zeng C; Wang J; Luo T; Li Y
Mult Scler Relat Disord; 2021 Oct; 55():103178. PubMed ID: 34384989
[TBL] [Abstract][Full Text] [Related]
22. MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease.
Carnero Contentti E; Okuda DT; Rojas JI; Chien C; Paul F; Alonso R
J Neuroimaging; 2023; 33(5):688-702. PubMed ID: 37322542
[TBL] [Abstract][Full Text] [Related]
23. Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis.
Nytrova P; Dolezal O
Front Immunol; 2022; 13():933415. PubMed ID: 36016923
[TBL] [Abstract][Full Text] [Related]
24. Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice.
Bruschi N; Boffa G; Inglese M
Eur Radiol Exp; 2020 Oct; 4(1):59. PubMed ID: 33089380
[TBL] [Abstract][Full Text] [Related]
25. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
Jarius S; Aktas O; Ayzenberg I; Bellmann-Strobl J; Berthele A; Giglhuber K; Häußler V; Havla J; Hellwig K; Hümmert MW; Kleiter I; Klotz L; Krumbholz M; Kümpfel T; Paul F; Ringelstein M; Ruprecht K; Senel M; Stellmann JP; Bergh FT; Tumani H; Wildemann B; Trebst C;
J Neurol; 2023 Jul; 270(7):3341-3368. PubMed ID: 37022481
[TBL] [Abstract][Full Text] [Related]
26. Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
Cortese R; Battaglini M; Prados F; Bianchi A; Haider L; Jacob A; Palace J; Messina S; Paul F; Wuerfel J; Marignier R; Durand-Dubief F; de Medeiros Rimkus C; Callegaro D; Sato DK; Filippi M; Rocca MA; Cacciaguerra L; Rovira A; Sastre-Garriga J; Arrambide G; Liu Y; Duan Y; Gasperini C; Tortorella C; Ruggieri S; Amato MP; Ulivelli M; Groppa S; Grothe M; Llufriu S; Sepulveda M; Lukas C; Bellenberg B; Schneider R; Sowa P; Celius EG; Proebstel AK; Yaldizli Ö; Müller J; Stankoff B; Bodini B; Carmisciano L; Sormani MP; Barkhof F; De Stefano N; Ciccarelli O;
Brain; 2023 Jun; 146(6):2489-2501. PubMed ID: 36515653
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging in neuromyelitis optica spectrum disorder.
Clarke L; Arnett S; Lilley K; Liao J; Bhuta S; Broadley SA
Clin Exp Immunol; 2021 Dec; 206(3):251-265. PubMed ID: 34080180
[TBL] [Abstract][Full Text] [Related]
28. Differentiate aquaporin-4 antibody negative neuromyelitis optica spectrum disorders from multiple sclerosis by multimodal advanced MRI techniques.
Zhang N; Sun J; Wang Q; Qin W; Zhang X; Qi Y; Yang L; Shi FD; Yu C
Mult Scler Relat Disord; 2020 Jun; 41():102035. PubMed ID: 32200338
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic performance of AI-based algorithms to discriminate between NMOSD and MS using MRI features: A systematic review and meta-analysis.
Etemadifar M; Norouzi M; Alaei SA; Karimi R; Salari M
Mult Scler Relat Disord; 2024 Jul; 87():105682. PubMed ID: 38781885
[TBL] [Abstract][Full Text] [Related]
30. Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
Shen T; You Y; Arunachalam S; Fontes A; Liu S; Gupta V; Parratt J; Wang C; Barnett M; Barton J; Chitranshi N; Zhu L; Fraser CL; Graham SL; Klistorner A; Yiannikas C
Ophthalmology; 2019 Mar; 126(3):445-453. PubMed ID: 30060979
[TBL] [Abstract][Full Text] [Related]
31. Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis.
Juryńczyk M; Klimiec-Moskal E; Kong Y; Hurley S; Messina S; Yeo T; Jenkinson M; Leite MI; Palace J
J Neurol; 2022 Jan; 269(1):269-279. PubMed ID: 34043042
[TBL] [Abstract][Full Text] [Related]
32. Microstructural white matter abnormalities in multiple sclerosis and neuromyelitis optica spectrum disorders: Evaluation by advanced diffusion imaging.
Kato S; Hagiwara A; Yokoyama K; Andica C; Tomizawa Y; Hoshino Y; Uchida W; Nishimura Y; Fujita S; Kamagata K; Hori M; Hattori N; Abe O; Aoki S
J Neurol Sci; 2022 May; 436():120205. PubMed ID: 35259556
[TBL] [Abstract][Full Text] [Related]
33. Relayed nuclear Overhauser effect weighted (rNOEw) imaging identifies multiple sclerosis.
Huang J; Xu J; Lai JHC; Chen Z; Lee CY; Mak HKF; Chan KH; Chan KWY
Neuroimage Clin; 2021; 32():102867. PubMed ID: 34751151
[TBL] [Abstract][Full Text] [Related]
34. [Characteristic features of radiological findings in multiple sclerosis and neuromyelitis optica].
Kawachi I; Nishizawa M
Nihon Rinsho; 2014 Nov; 72(11):1976-82. PubMed ID: 25518380
[TBL] [Abstract][Full Text] [Related]
35. Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review.
Lin TY; Chien C; Lu A; Paul F; Zimmermann HG
Expert Rev Neurother; 2021 Oct; 21(10):1101-1123. PubMed ID: 34551653
[TBL] [Abstract][Full Text] [Related]
36. Cervical cord myelin water imaging shows degenerative changes over one year in multiple sclerosis but not neuromyelitis optica spectrum disorder.
Combes AJE; Matthews L; Lee JS; Li DKB; Carruthers R; Traboulsee AL; Barker GJ; Palace J; Kolind S
Neuroimage Clin; 2017; 16():17-22. PubMed ID: 28725551
[TBL] [Abstract][Full Text] [Related]
37. Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
Liao MF; Chang KH; Lyu RK; Huang CC; Chang HS; Wu YR; Chen CM; Chu CC; Kuo HC; Ro LS
BMC Neurol; 2014 Nov; 14():218. PubMed ID: 25433369
[TBL] [Abstract][Full Text] [Related]
38. Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.
Schumacher S; Pache F; Bellmann-Strobl J; Behrens J; Dusek P; Harms L; Ruprecht K; Nytrova P; Chawla S; Niendorf T; Kister I; Paul F; Ge Y; Wuerfel J; Sinnecker T
MAGMA; 2016 Jun; 29(3):535-41. PubMed ID: 27072685
[TBL] [Abstract][Full Text] [Related]
39. Dorsal medulla surface texture: Differentiating neuromyelitis optica spectrum disorder from multiple sclerosis.
Okuda DT; Stanley T; McCreary M; Smith AD; Burgess KW; Wilson A; Guo X; Moog TM
J Neuroimaging; 2022 Nov; 32(6):1090-1097. PubMed ID: 36181675
[TBL] [Abstract][Full Text] [Related]
40. Update on pathology of central nervous system inflammatory demyelinating diseases.
Kalinowska-Łyszczarz A; Guo Y; Lucchinetti CF
Neurol Neurochir Pol; 2022; 56(3):201-209. PubMed ID: 35758517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
